Discontinuation report METOCLOPRAMIDE INJECTION USP
Report ID | 135380 |
Drug Identification Number | 02243563 |
Brand name | METOCLOPRAMIDE OMEGA |
Common or Proper name | Metoclopramide Hydrochloride Injection USP |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | METOCLOPRAMIDE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 1 x 30mL vial / fiole |
ATC code | A03FA |
ATC description | PROPULSIVES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-03-09 |
Remaining supply date | 2022-09-09 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | 10 x 2 mL vial / fiole available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2021-03-10 | English | Compare |
v2 | 2021-03-09 | French | Compare |
v1 | 2021-03-09 | English | Compare |
Showing 1 to 3 of 3